share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

SEC announcement ·  May 6 17:00
Summary by Moomoo AI
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed a series of transactions involving the company's Class A Common Stock. On May 1, 2024, Dmytruk acquired a total of 108,127 shares through the exercise of derivative securities. The following day, on May 2, 2024, he sold 47,806 shares in an open market transaction at a price of $0.845 per share, resulting in a total sale value of $40,396.07. After these transactions, Dmytruk's direct holdings in Ginkgo Bioworks totaled 925,400 shares.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed a series of transactions involving the company's Class A Common Stock. On May 1, 2024, Dmytruk acquired a total of 108,127 shares through the exercise of derivative securities. The following day, on May 2, 2024, he sold 47,806 shares in an open market transaction at a price of $0.845 per share, resulting in a total sale value of $40,396.07. After these transactions, Dmytruk's direct holdings in Ginkgo Bioworks totaled 925,400 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more